A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin. We reached out to ...

British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up to $1 billion, expanding its treatments for cancer. EsoBiotec's ...

TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at $66.64. Discover outperforming stocks and invest ...

AstraZeneca (AZN) stated: “Leon Wang, Executive Vice President International and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese authorities. Our China ...

AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival (OS) in a phase 3 trial. The latest miss happened in breast cancer, a ...

AstraZeneca’s booming oncology business has won over cancer patient groups. Having languished down the leaderboard in the past, the drugmaker vaulted (PDF) over many rivals in PatientView’s ...

Png Cheong Boon, chairman of Singapore's Economic Development Board (EDB) also said: "We welcome AstraZeneca's decision to establish a manufacturing presence in Singapore for the first time.

AstraZeneca has a wide portfolio of in-house ADCs, which includes six wholly owned ADCs in clinic and more in pre-clinical development. Economic Development Board Chairman Png Cheong Boon welcomed ...

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...

By Rebecca Robbins AstraZeneca has started to pull its Covid-19 vaccine from global markets because of low demand, the pharmaceutical giant said. The decision closes the chapter on a shot that was ...

Nikos Pekiaridis / NurPhoto via Getty Images AstraZeneca's sales of cancer drugs helped the pharmaceutical firm beat first-quarter estimates for earnings and revenue. Sales of oncology treatments ...

March 19 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc (FUSN.O), opens new tab for $2 billion in cash as the Anglo ...